To consolidate or not, and the impact on negotiations in a joint venture context
When forming a joint venture or a consortium (JV), each party is likely to have a specific view about whether or not they wish to...
When forming a joint venture or a consortium (JV), each party is likely to have a specific view about whether or not they wish to...
A key topic of interest this year is the extent to which companies are following the new PEG guidelines on share capital resolutions. In...
On January 25, 2023, the Securities and Exchange Commission (SEC) published proposed Rule 192 pursuant to Section 27B of the Securities...
Our latest survey of the last decade of acquisitions and investments found that the 40 DAX and 50 MDAX companies were more cautious in...
Yesterday the European Commission put out for consultation a draft Implementing Regulation on proceedings pursuant to the Foreign...
As issuers and investors get to grips with the reforms announced by the UK Chancellor in December 2022 (including a policy note and
There’s no escaping it – US securities and tender offer laws are implicated in essentially every public M&A deal, no matter where in...
We anticipate a year of reserved optimism in the life sciences industry for 2023. Despite uncertain financial markets and pricing...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net